Among this year’s awardees, selected proposals showcase a broad spectrum of science, from microscopy to computation to molecular techniques, and demonstrate the myriad ways in which Expansion Awards can impact the trajectory of science. The Expansion Awards give our research teams the ability to move hypotheses forward from in vitro models to proof-of-concept demonstrations of efficacy in human tissue, bringing new pharmacological treatments many steps closer to the clinic; the ability to test and validate brand new sequencing approaches, that for the first time, may allow researchers to assess all types of cellular RNAs at once; and, offer them the gift of time, accelerating projects by up to a full year, increasing the potential impact of publications and freeing these teams up to explore their next great ideas in the single ventricle space. And, while the term of these awards is only 12 months, these investments will continue to offer returns in the long term – next generation equipment and technology housed in labs that are devoted to single ventricle research will outlive any single project and will continue to drive future discovery years beyond the limits of our initial support.

For more details on all Additional Ventures awardees, see our Funded Studies page.